Glaciers are melting worldwide. In some regions, they could even disappear completely. Looking at the number of glaciers ...

Globally, RHD remains a leading cause of mortality in low- and middle-income countries, while NRVHD is increasingly prevalent in high-income nations.

Background Stroke remains a significant global health challenge, especially in low- and middle-income countries, despite ...

India’s gem and jewellery exports rose 19 per cent in November to $2.52 billion from $2.09 billion a year earlier, driven by ...

Other than "6 7," the only thing you were more likely to hear about in 2025 was "Labubu." Created ten years ago by Hong Kong ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

DelveInsight's Amyotrophic Lateral Sclerosis Market Insights report includes a comprehensive understanding of current treatment practices, amyotrophic lateral sclerosis emerging drugs, market share of ...

Despite this concentration at the stock level, the ETF maintains its broad geographical diversification across 23 developed markets, even as the U.S. weighting remains predominant. Fresh MSCI World ...

Oncology-related rare diseases represented the largest share of the orphan drugs market, accounting for around 41% (USD 91.7 billion). This segment is driven primarily by hematologic malignancies, ...

International stock markets tracked Wall Street gains and U.S. stock futures pointed to a higher open ahead of the Thanksgiving holiday. The higher close in the prior session was broad-based, even as ...

The Buffett effect is in full force. Google jumped more than 6%, pulling U.S. markets higher. The Nasdaq rallied 2.69% - its best session since May - while Broadcom and Tesla surged 11% and nearly 7%.

The summary highlights significant developments in health, including FDA official Richard Pazdur's concerns over expedited drug approvals, ALS research offering hope for reversal, criticism of the ...